Feng Zhang, a groundbreaking professor of neuroscience at MIT and a leader in gene editing, discusses his pioneering work with CRISPR technology. He explores the revolutionary journey of CRISPR, from its discovery to its potential in treating genetic diseases like sickle cell anemia. Zhang also addresses the ethical debates surrounding gene editing, particularly concerning germline modifications. He shares insights from his personal journey, the impact of mentorship, and the future potential of genetic medicine, highlighting both challenges and innovative solutions in the field.

CRISPR pioneer Feng Zhang and Regeneron Pharmaceuticals head scientist George Yancopoulos share insights at the STAT Breakthrough Summit East. Topics include gene therapy costs, GLP-1 story twists, and a pie contest. The discussion also covers the future of healthcare, interdisciplinary teamwork in research, innovative allergy treatments, and muscle growth potential with medication.